:: Previous BioPort Production :: FDA Lot-Release Authorizations

FDA Lot-Release Authorizations

These memos show the authority for the manufacturer to release anthrax vaccine from the manufacturing plant. Each lot of every vaccine produced in the United States must be individually released in this way, after having been tested for sterility, purity, potency, and general safety. Lot-release tests are performed by the manufacturer and audited by FDA.

--SELECT-- FAV008 FAV013 FAV014 FAV015 FAV016 FAV017 FAV018 FAV019 FAV020 FAV022 FAV023 FAV024 FAV025 FAV027 FAV028 FAV029 FAV030 FAV031 FAV032 FAV033 FAV034 FAV035 FAV036 FAV037 FAV038 FAV039 FAV041 FAV043 FAV044     labeling info FAV047 FAV048B